11 / 64
11
Thursday, 24 September 2015
|
Scientific Programme
S-02
Symposia
11:30–13:00
Oxford, 2nd Floor
Models for understanding negative symptoms
Chairs: S. Kaiser, Zurich, Switzerland
T. Lincoln, Hamburg, Germany
S-02-001
Effect of different models on negative symptom
prevalence
J. P. Lyne, Dublin, Ireland
M. Clarke
S-02-002
What impairs social interaction in patients with
negative symptoms? Interpersonal conse-
quences of blunted facial expressiveness
M. Riehle, Hamburg, Germany
T. M. Lincoln
S-02-003
Negative symptoms as dysfunctional decision-
making
S. Kaiser, Zurich, Switzerland
S-02-004
Neurobiological correlates of reward learning
and cognitive deficits – relevance for negative
symptoms
F. Schlagenhauf, Berlin, Germany
S-03
Symposia
11:30–13:00
Harvard, 1st Floor
What happens in adolescence? Develop
mental aspects in developing psychosis
Chairs: F. Schultze-Lutter, Bern, Switzerland
P. Uhlhaas, Glasgow, United Kingdom
S-03-001
Impact of age on the prevalence and clinical
significance of risk symptoms in 8- to 40-year-
olds of the general population
F. Schultze-Lutter, Bern, Switzerland
C. Michel, B. G. Schimmelmann
S-03-002
Adolescent brain development and the onset
of psychosis
S. Wood, Birmingham, United Kingdom
S-03-003
Development of neural oscillations during ad-
olescence: relevance of the development and
early detection of psychosis?
P. Uhlhaas, Glasgow, United Kingdom
S-03-004
Developing psychosis: a mentalization-based
perspective
M. Debbané, Geneva, Switzerland